Increased cellular avidity upon combining multi-targeting and co-stimulation leads to enhanced CAR-T cell sensitivity and persistenceAvailable on-demand
CAR T: Dual-targeted cell therapy targeting BCMA and GPRCD5 to prevent relapsed multiple myelomaAvailable on-demand
